- Home
- » Tags
- » Mitomycin C
Top View
- Cancer Drug Costs for a Month of Treatment at Initial Food
- Concomitant Radiochemotherapy with Temozolomide in Non-Selected Patients with Newly Diagnosed High-Grade Gliomas
- The Current Situation of 5-Aminolevulinic Acid Mediated Photodynamic Therapy in Bladder Cancer
- Mariyyah Madkhali's Thesis Paper Editted-17
- PFKFB3 Inhibition Sensitizes DNA Crosslinking Chemotherapies by Suppressing Fanconi Anemia Repair
- Types of DRUGS ACTING on DNA (In Chapter 9) Intercalating Agents
- Interstrand Crosslinks -Induction and Repair
- Product Information Sheet
- Chemotherapy in Patients with Metastatic Prostate Cancer
- Mutagenicity of Several Classes of Antitumor Agents to Salmonella Typhimurium TA98, TA100, and TA921
- Randomized Phase II Trial Assessing Estramustine and Vinblastine
- Single-Agent Paclitaxel in Advanced Anal Cancer After Failure of Cisplatin and 5-Fluorouracil Chemotherapy
- Antitumor Effect of Combination of Hyperthermotherapy and 5-Aminolevulinic Acid (ALA)
- A Phase I and Pharmacokinetic Study of Temozolomide and Cisplatin in Patients with Advanced Solid Malignancies1
- Mitomycin-C Use in Ophthalmology
- Cervical Cancer Treatment Regimens
- Chemo Brain Or Tumor Brain
- Inhibition of Radiation and Temozolomide-Induced Invadopodia Whitehead Et Al
- Β-Catenin Signalling and Mre11–Rad50–Nbs1 Complex in the Repair of Cisplatin-Induced DNA Cross-Links
- Antitumour Treatment: Mitomycin C: a Clinical Update
- 5-Fluorouracil (4 Day) and Mitomycin Chemoradiation Therapy
- Enhanced Lipid Metabolism Induces the Sensitivity of Dormant Cancer Cells to 5-Aminolevulinic Acid- Based Photodynamic Therapy
- Cancer Drug Costs for a Month of Treatment at Initial Food and Drug Administration Approval
- Cyclophosphamide and Doxorubicin Contribute to Onset of Chemobrain by Altering Epigenetic Factors DNMT1, DNMT3A, Tet1, Mecp2, and CBP
- Adverse Mucocutaneous Reactions Related to Chemothera- Peutic Agents – Part II Reações Tegumentares Adversas Relacionadas Aos Agentes Antineoplásicos – Parte II
- Phase I Clinical Trial of Temozolomide and Methoxyamine (TRC-102), an Inhibitor of Base Excision Repair, in Patients with Advanced Solid Tumors
- Enhanced Cytotoxicity of Mitomycin C in Human Tumour Cells with Inducers
- Mitomycin C and Fluorouracil Chemoradiation Gynaecological
- Photodynamic Diagnosis-Assisted Transurethral Resection Using Oral
- And Taxane-Pretreated Metastatic Breast Cancer
- Mitomycin) for Pyelocalyceal Solution Patients for Signs and Symptoms of Ureteric Obstruction
- November 22, 2020 Molnlycke Health Care, US LLC Leonard Stewart
- Repurposing of Anticancer Drugs for the Treatment of Bacterial Infections Valerie W. C. Soo1£, Brian W. Kwan 1£, Héctor Queza
- Mitomycin C and Fluorouracil (MMC and 5Fuanal)
- Results Oftreatment with Topical Mitomycin C 0-02% Following
- Powerpoint Presentation
- Treatment Factors Associated with Long-Term Survival Following Cytoreductive Surgery and Regional Chemotherapy for Patients with Malignant Peritoneal Mesothelioma
- Chemotherapy-Related Neurotoxicity
- The Mystery of Chemotherapy Brain: Kynurenines, Tubulin and Biophoton Release PETER P
- Arsenic Trioxide Inhibits Proliferation of Rabbit Tenon's Capsule Fibroblasts After Trabeculectomy by Downregulating Expressio